Shilstine 50mg Injection
By Shilstine
Rx
5ml Injection in a Vial

Composition
Calcium Leucovorin(50mg)

Manufacturer - Shilpa Medicare Ltd
12-6-214/A1, Hyderabad Road, Raichur – 584 135, Karnataka, India.

Expires on or after
November, 2026

liver
Caution is advised when using Shilstine 50mg Injection in patients with liver disease. Limited information is available regarding its use in such cases. It is important to consult with your doctor before using this medication to ensure its safety and effectiveness for individuals with liver issues.

kidney
Limited information available on Shilstine 50mg Injection use in patients with kidney disease. Consult doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Shilstine 50mg Injection.

driving
"When using Shilstine 50mg Injection, your ability to drive is typically unaffected."

pregnancy
Shilstine 50mg Injection may not be safe to use during pregnancy. Limited human studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor regarding this.

breastfeeding
Information about using Shilstine 50mg Injection during breastfeeding is not provided. Therefore, it is advised to consult your doctor regarding its safety during breastfeeding.
| Habit Forming | No |
| Chemical Class | Glutamic Acid Derivatives |
| Therapeutic Class | - |
| Action Class | Cytoprotective agents- methotrexate |
₹238.5
₹265
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024
